Top 10 Holdings (14. 58%: Halozyme Therapeutics Inc:XLY News. XBI - SPDR® S&P Biotech ETF - Review the XBI stock price, growth, performance,. by Sweta Killa Published on September 18,2023. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. IBB has a higher expense ratio than XBI (0. SPDR SERIES TRUST's SPDR (R) S&P (R) Biotech ETF (XBI) has disclosed 141 total holdings in their latest N-PORT filing with the SEC for the portfolio date of 2023-06-30. 2401 Millstream Rd 125 Victoria BC. XBI is suitable for investors seeking to. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. Last Price Today's Change Today's Volume : Prospectus. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. Asset type. Diversification. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Rated on Jun 30, 2023 Published on Jun 30. Its top 10 holdings account for approximately 16. This index comprises companies in the biotech industry that are a part of the S&P Total Market Index. LABU. At midday the XBI is rebounding indicating there is buying interest near $101. XBI. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. XBI: SPDR S&P Biotech ETF - Fund Holdings. Stocks. Major Holdings. 46% YTD Daily Total Return ETF Summary. Both ARKG and XBI are ETFs. 19%. 97 and standard deviation of 36. 47 and a beta of 0. The stock holdings of the XBI tends to be re. 0. 9%. 97. 01%). 60%. Find exchange traded funds (ETFs) whose sector aligns with the same commodity grouping as the symbol you are viewing. Better trading starts here. 81% of the total fund's. 35% for XBI, but SBIO yields 2. 12% over the last 12 months (as of 07/18/2023). 35% Expense Ratio 20 40 60 per page Viewing 1-20 of 134 matches 1 2 3 4 5 XBI: SPDR S&P Biotech ETF - Fund Holdings. 75. Message board - Online Community of active, educated investors researching and discussing Novavax Inc. 32% Category Average 45. XBI is lower by 45% over the past two years, while the S&P 500 ETF (SPY Quick Quote SPY - Free Report) is higher by 8. 06 as the 52 week high point — that compares with a last trade of $112. Performance. NBI IBBQ XBI BTK FBT IBB Other Topics Indexes Stocks ETFs Coronavirus Prableen Bajpai Prableen Bajpai is the founder of FinFix Research and. ETF Channel Staff - Friday, October 20, 6:48 AM. 01 %IBB: iShares Biotechnology ETF: 0. Top Holdings . The main reason for this is the additional risk mitigation an ETF provides given its myriad holdings within a sector. 98 and standard deviation of 40. The following charts reflect the allocation of WCLD's underlying. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. XBI ETF’s holdings offer significant diversification. 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. 17% for the trailing three-year period, which makes XBI a high. 0. Holdings: 136: Inception Date: Jan 31, 2006: About XBI Fund Home Page The SPDR S&P BIOTECH ETF (XBI) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The company’s fifty day. It is gross of any fee waivers or expense reimbursements. 68%. Net Expense Ratio. Our MRNA ETF report shows the ETFs with the most MRNA exposure, the top performing MRNA ETFs, and most popular MRNA ETF strategies. Also I like this style of etf from power shares because the holdings are less weighted in the top two powerhouses (Amgen and Gilead for PJP) than "traditional" ETF's. 66%. For investors that want to rely on modern portfolio theory rather than assessing biotechnology companies, this is a solid option. 19%. Top 10 Holdings 16. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. 27. 7. SPDR® S&P Biotech ETF XBI: NYSE Arca All Holdings as of 11/15/2023 Holdings are subject to change. Learn everything you need to know about SPDR® S&P Biotech ETF (XBI) and how it ranks compared to other funds. 11. Seeking AlphaXBI vs. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. XBI has a higher expense ratio than XLV (0. BBC vs XBI. 3. Index Dividend Yield The weighted average of the underlyings’ indicated annual dividend A high-level overview of SPDR® S&P Biotech ETF (XBI) stock. Both LABU and XBI are ETFs. 22%: Revolution. 26 during this last 52-week period. 98 and standard deviation of 40. XBI's 120. The ETF has lost about -22. The sale of ETFs is subject to an activity assessment fee (from $0. Snapshot: XBI. The XBI underweights large cap biotechs and its top holdings include volatile smaller caps at about 1-2%. Reserve your copy today. Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). 96 on December 31, 2021, to $83 per share at the end of 2022. SBIO holds 79 companies vs. Fund size is a good indication of how many other investors trust this fund. 4% of the stocks in our database. It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. Cryptocurrency. Meanwhile, XBI equal weights its holdings. With about 156 holdings, it effectively. ($423. XBI provides a unique investment focus, as its holdings are largely small and mid-cap biotech firms rather than larger pharmaceutical companies such as Pfizer and Johnson & Johnson . com if you have any further questions. The company has an 88. Latest SPDR® S&P Biotech ETF (XBI:PCQ:USD) share price with interactive charts, historical prices, comparative analysis, forecasts,. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. (“SSGA FM” or the “Adviser”), the investment adviser to the Fund, either may invest the Fund's assets. A collar strategy is a protective option strategy constructed by writing a call and buying a put with the same expiration date while being long the underlying security. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. XBI has traded between $62. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. In addition, the recent spike in volatility has increased option prices even. 94 as the 52 week high point — that compares with a last trade of $116. In contrast, most. Search tickers or categories. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. 54%. 67% Symbol Company Name Industry Percent of Assets MRTX Mirati Therapeutics Inc Biotechnology 2. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. For XBI holdings in the human health space, I think you also have to account for regulatory and policy risk tied to reimbursement rates for expensive drugs. (XBI) SPDR S&P Biotech ETF Stock Price, Holdings,. Up vote for PJP but it is pharmaceutical focused and technically not as broad as other biotech ETF's, though the top 10 holdings are comparable. N/A. 10(-0. Stock Analysis Chart Headlines Holdings Ownership Ratings. VEEV. 03 per $1,000 of principal). 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. 09% of its total assets under management. S. Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. 46M), Matrix Capital Management Company LP ($188. XBI: Head-To-Head ETF Comparison. 45% vs 0. Growth of Hypothetical $10,000. SPDR® S&P Biotech ETF XBI: NYSE Arca . Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U. Twin City Holdings Ltd. 58%: Halozyme Therapeutics Inc:Dollar Tree Inc. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. Both XBI and XLV are ETFs. It is gross of any fee waivers or expense reimbursements. XBI is one of a handful of biotech ETFs available, offering exposure to a corner of the market that can perform well during periods of consolidation and is capable of big jumps in the event of major drug approvals. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. Trade XBI with: Price/Earnings ttm 17. 40. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. 78% so far this year and in the past one year (as of 11/20/2023), respectively. 15 billion assets under management. 40. XBI Description. 2013. Taking a look at the XBI, it peaked at $174. Brazil. 13%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. IBB vs. GrowthStrategy: Traditional growth investing is an investment. AMGN. 84%: Other: 0. "The top five holdings in XBI, as of Dec. Further, the fund owns $6. RGLD. It has a total of 153 holdings. Below is the comparison between VHT and XBI. 42 billion worth of. The XBI has been a leader beating other ETFs YTD, up about 35% until today. 78% so far this year and in the past one year (as of 11/20/2023), respectively. Advertisement. 9% vs -5. 79 as the 52 week high point — that compares with a last trade of $76. ARKG vs XBI Fund Comparison . BlackRock Files for Spot Ethereum ETF. While this ETF allocates. According to data from U. 87. $5. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol. 0. The quantity of holdings in the Fund will be based on a number of factors, including asset size of the Fund. 94 per share, with $107. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. XBI has traded between $64. 58% and is down about -14. 58%). 45% and is down about -9. XBI vs ARKG. 0. It's trading down (17%) versus LABU, down (68%) in one-year performance. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Performance and Risk. Its price to cash flow multiples is about 13. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. NAV as of Nov 16, 2023. Year-to-date, the SPDR S&P Biotech ETF has lost about -15. Visitors trend 2W 10W 9M. Mon, Oct 30, 12:50 PM ET, Market News Video. XBI Holdings 5 Beaten-Down ETFs to Buy Now. View Top Holdings and Key Holding Information for Direxion Daily S&P Biotech Bull 3X Shares (LABU). In the institutional-holders-of-XBI table below, the initial column indicates the name of each top institutional holder of XBI, with a link to that fund's top holdings. 1% over the past year to close the last trading session at $81. LABD. The top 10 holdings account for about 14. XLV comparisons: including fees, performance, dividend yield, holdings and technical indicators to make a better investment decision. ETF Report Card. 60 as the 52 week high point — that compares with a last trade of $77. 47% vs -5. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. S. Regeneron has an overall rating of B in our POWR Ratings, where it outranks 79. underlying holdings of the fund. We have highlighted five ETFs from different. Site search Search. " The 12-month stock price forecast is $22. 87. Additionally. All 142 XBI Holdings. Holdings; Performance; Risk; Advertisement. However, XBI has a built-in advantage that was mentioned earlier: It owns stocks in relatively equal weights. Fund Size Comparison. XBI is an equal-weight passively-managed biotech ETF while ARKG is an actively-managed genomics ETF. Total net assets. XBI has a beta of 0. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Export data to Excel for your own analysis. 7,569,600. 44 per share, with $92. Chart. $6. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. $0. Lenders are funds or individuals that own the security that have indicated to. As illustrated more by the next two charts, comparing the top 10 holdings XBI and IBB. Looking at the chart above, XBI's low point in its 52 week range is $100. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Seeks to track a modified. In addition to holding 155 positions, its top 10 holdings make up just 14. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 47%. As of Oct 31 2023. Components of. 71% of total assets under management. A comparison between ARKG and XBI based on their expense ratio, growth, holdings and how well they match their benchmark performance. Currency in USD Follow 2W 10W 9M 72. 35%). Currency in USD. SPDR S&P Biotech ETF ( NYSEARCA: XBI) is likely in the early to mid stages of a period of underperformance, both versus its larger-cap peers and the broad US stock market. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. Analyst Forecast. 97. LABU has a lower 5-year return than XBI (-46. Looking at the chart above, XBI's low point in its 52 week range is $63. 88 ; Annual Dividend & Yield 0. So far this year, XBI has lost about -5. 00. No, even the large cap biotechs get pumped before a final FDA decision on a drug in their pipeline and usually have a sell off after on profit taking or a failed decision. Both IBB and XBI have a similar number of assets under management. 2% Category Average. Below is the comparison between BBH and XBI. Seeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocks. FBT has a higher 5-year return than XBI (-0. VHT has a lower expense ratio than XBI (0. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. 79 as the 52 week high point — that compares with a last trade of $133. View and export this data back to 2006. XBI, MDGL, ARWR, CYTK: Large Inflows Detected at ETF. 9%. 0 reviews. 51 on Tuesday. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. Currency in USD. Total healthcare and life sciences M&A was about $71. 66 +2. Below is the comparison between LABU and XBI. This is the case with most of XBI's holdings which do not yet have products at commercialization stage, except for notable exceptions including Moderna (NASDAQ: MRNA) and Regeneron (NASDAQ: REGN). Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. TipRanks | Stock Market Research, News and Analyst Forecasts. 1% over the past year to close the last trading session at $81. 20. Its fund flows were negative $259. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare . Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. In depth view into XBI Price including historical data from 2006, charts and stats. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. ARGX. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. ValueStrategy: Traditional value investing is an investment strategy where stocks are selected that trade for less than their intrinsic values. ETF Constituents for S&P Biotech SPDR (XBI) provide detail on the individual stock holdings that make up the ETF. View the latest ETF prices and news for better ETF investing. In a true biotech bust, where investors can't bear the thought of owning a biotech company ever again, there's little to stop XBI from falling to a near 1 P/B ratio when 80% of its top holdings. XBI Price: 68. Free ratings, analyses, holdings, benchmarks, quotes, and news. The gross expense ratio is the fund’s total annual operating expenses ratio. Mettler-Toledo International Inc. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. 1% which highlights the scope of the fund and diversification away from company-specific risks. The fee is slightly higher for SBIO - . XBI SPDR S&P Biotech ETF Price: undefined undefined Change: Category: Health & Biotech Equities Last Updated: Nov 21, 2023 Vitals Issuer State Street Brand. 76% allocation. Complete SPDR S&P Biotech ETF funds overview by Barron's. $72. Price Chart. 73. Krane Carbon Cfc (138001) 18. Performance and Risk The ETF has lost about -9. 66% so far this year and in the past. 66 +2. 81. 35% ; Sectors:. In XBI, the top five holdings together represent only 9. This large ETF has performed well and is at its year highs, but will it continue to outperform? With takeover activity occurring in the sector, how will this ETF benefit? How is this ETF. Holdings Details. XBI SPDR S&P Biotech ETF ARKG ARK Genomic Revolution ETF IBB iShares Biotechnology ETF IHI iShares U. VHT has a higher 5-year return than XBI (7. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. The iShares Biotechnology ETF seeks to track the investment results of an index composed of U. 78% in the last one year. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. 86% upside for this ETF looking through to the average analyst targets of the underlying holdings. 46% YTD Daily Total ReturnETF Summary. London. This was a 3 for 1 split, meaning for each share of XBI owned pre-split, the shareholder now owned 3 shares. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. All 142 XBI Holdings. Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. The Composition of the XBI is the Key. 80% of total assets under management. Find the latest SPDR S&P Biotech ETF (XBI) stock quote, history, news and other vital information to help you with your stock trading and investing. 71%: Number of Holdings 64: Price/Book Ratio Price/Book Ratio. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. DLTR. **Close price adjusted for splits and dividend and/or capital gain distributions. In its most recent earnings release, President and Chief Executive Officer Christopher A. February 15, 2023 — 10:47 am EST. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Morningstar Medalist Rating. 96%, and is down about -5. Net Expense Ratio. 1% vs 0. The famed investor's Berkshire Hathaway (. If Moderna's share price. 52 (-1. LABU has a higher expense ratio than XBI (1. View Holdings As of 09/30/2023. Notable ETF Outflow Detected - XBI, CYTK, CCXI, SRPT. 15 per share, with $174. Veeva Systems. 35 %LABU: S&P Biotech Bull 3X Shares ETF:Finally, our fifth stock in our POWR Ratings/XBI combination strategy is Regeneron . 35%). 5. Performance and Risk. 32% of the total portfolio assets. 61%) At close: 04:00PM ESTSeeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: Biotechnology. The biopharma industry has seen a recent upswing in mergers and acquisitions (M&A). The biopharma industry has seen a recent upswing in mergers and acquisitions (M&A). The weighted harmonic average of closing market price divided by. 93% of its total assets under management. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. 73% so far this year and is down about -39. View Top Holdings and Key Holding Information for VanEck Gold Miners ETF (GDX). ETF Strategies. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. XBI, MDGL, SGEN, NTRA: ETF Outflow Alert. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. 66%, and is down about -18. Top 10 Holdings XBI. 61%) At close: 04:00PM EST Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: Biotechnology. The split for XBI took place on September 11, 2015. com Ltd. XBI holdings. Single Cell Genomics Workflow Automation Cell Analytics Lab Equipment Spatial Genomics Lab Equipment. Both VHT and XBI are ETFs. VHT vs XBI.